Study on the Pharmaceutical E-commerce B to C Model from Perspective of Transaction Costs

2014-03-06 10:11:19ZHANGLeiXINGHuaWUYang
亚洲社会药学杂志 2014年2期

ZHANG Lei, XING Hua, WU Yang

(School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China)

Study on the Pharmaceutical E-commerce B to C Model from Perspective of Transaction Costs

ZHANG Lei, XING Hua, WU Yang

(School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China)

Objective To probe into the reasons why pharmaceutical E-commerce develops slowly and to promote the E-commerce applications to pharmaceutical retail industry. Methods Pharmaceutical e-commerce and traditional retail models were compared, and some suggestions were raised from the perspective of transaction costs. Results and Conclusion At present, transaction costs of the emerging pharmaceutical E-commerce B to C model have not been reduced much compared with the traditional retail model, that is, E-commerce B to C model has not gained a significant advantage. Therefore, government, enterprises and other parties should cooperate to cut down the transaction costs of drugs via the Internet so as to promote the E-commerce applications to the pharmaceutical retail industry.

transaction cost; pharmaceutical e-commerce; online drug store; pharmaceutical retail

China Electronic Commerce Research Center monitoring data shows that in 2011 China’s online retail market transactions exceeded 800 billion, reaching 801.9 billion Yuan, an increase of 56%[1], however the latest statistics of China’s online pharmacy Council data shows that in 2011 the scale of medicine B to C was about 400 million Yuan, only five online pharmacies sales reached more than 50 million Yuan[2], Compared with other online business such as clothing, appliances, books, B to C medicine e-commerce development is falling behind a lot.

There are some reasons for this phenomenon, such as policy bottlenecks, strict supervision and institutional backwardness etc., but the major cause is that we are unable to find a suitable way to develop medical e-commerce B to C. Therefore, the author studied on the pharmaceutical B to C model from the perspective of transaction costs and found that under the current conditions, the transaction costs hasn’t been lowered too much compared to traditional retail model which lead to the slow development.

1 The overview of transaction cost

1.1 The concept of transaction cost

The transaction cost refers to the amount of money taken to complete a deal, and it also refers to all the amount of time and money spent during a transaction[3].

1.2 The contents and categories of transaction cost

In general, transaction cost could be divided into the following items.

Search cost: collecting information of product and transaction.

Information cost: the cost to get information of transaction and information exchange.

Bargaining cost: the cost to contract, price, quality negotiation.

Decision cost: internal cost taken to complete relevant decision and sign a contract.

Supervision transaction cost: cost to monitor transaction abides by contract or not such as tracking product, supervision, inspection etc..

Breach cost: The cost taken to tackle breach of contract.

Dahlman (1979) takes the transaction activities into categorization and he believes transactions include: The cost taken to search information, negotiation and decisionmaking, signing contract, supervision, execution and transfer. In brief, transaction cost means all the fees involved with searching information, negotiation, implementingtransaction etc when the transaction is ongoing.

1.3 Transaction cost during e-commerce

Transaction cost of e-commerce refers all the money spending on software and hardware, learning the technology, getting information, online payment, information safety, logistics distribution, sales service etc[4].

2 Costs comparison between e-commerce and traditional transaction model

2.1 Buyer /Consumer’s perspective

2.1.1 Searching for price of drug

Under the model of traditional transaction, it takes a lot of time and transportation expense for consumers to find drugs they want. With the booming development of chain-retail and individual drug store, consumers take fewer amounts of time and money than before to search for what they want. Under the medical B to C model, buyers only need to click the keyboard and get what they want through Internet with a little internet costs. And it even means far less to those who use the leisure time or monthly Internet package. Therefore, it may count nothing under the medical and pharmaceutical B to C business model for consumers to search for what they want.

2.1.2 Costs of comparing drugs

Consumers usually spend certain amount of time and travel expense to compare same drugs in traditional drug stores. However, under the model of medical and pharmaceutical business, consumers only have to compare them online, which is hard to f i nd the quality of the drugs. Therefore, consumers have to rely on name-brand drugs and it is easier to compare the prices in online stores, the costs of comparing online can be little. While for those that are not name-brand, it is hard for consumers to tell the quality.

2.1.3 Costs for drug checking

Under the model of traditional drug retail, buyers will pick drug on the spot and they don’t spend certain money for drug inspection like package and expire date. Under the model of medical and pharmaceutical B to C, due to features of cyberspace, consumers cannot guarantee the quality of drugs which leads to the risk of uncertainties for drug deals. This uncertainty itself doesn’t have transaction cost, but later on, it can cause some transaction costs after buying.

2.1.4 Drug negotiation cost

Under the model of traditional drug transaction, buyers usually express the purchasing intention and then both parties will negotiate about price and other issues. If the price is ok, then deal will be done and vice versa. In chain stores, everything is set and both parties could lower the negotiation cost to a certain degree. Under the model of e-commerce, it is almost the same for consumers and seller and they will not talk about the price.

2.1.5 Costs of purchasing drugs and payment

Traditional transaction means money for products, which is an easy and direct process and the transaction cost is less. While in e-commerce, buyers and sellers usually don’t meet face to face and purchase and payment are separated in terms of time and space. Whether you choose to pay f i rst and then get product later or to get products f i rst and pay later, it may also cause some problems. In recent years, things like online bank have released the e-payment, which is convenient and fast and it could lower the cost of transaction. So, if we can improve the safety of e-payment, e-commerce could lower the transaction cost to a certain point and it will be accepted by most buyers.

2.1.6 Costs of drugs delivery

Under the model of traditional drug retail transaction, buyer will take drugs home and delivery cost can be none. While under the model of e-commerce, delivery is the key factor which can decide the fate of this model. First of all, drug logistics has higher requirement for temperature, and if it cannot meet the standard, then drug value will be greatly impacted. Secondly, B to C model is actually a retail business which has many potential buyers but few real purchasers. So, the delivery cost of small amount is a little higher. Thirdly, retail products are of low value and could not show the advantage of online price and it may cause higher delivery cost than off-line. Therefore, E-Commerce model will cost buyer much more than the traditional model.

2.1.7 Costs of return drugs

This includes return fees and after sales service. For drug is one-time consumption, and after sales service couldbe ignored. For returning cost, under the traditional model, buyers will check the drug package carefully and then decide to buy. So, in general, the chances of return drugs are few. While in e-commerce, a lot of uncertainties will happen during delivery that will cause the return of products. Once this happens, consumers will spend extra time and money on this and it can raise the cost.

2.2 Seller/Retailer’s perspective

The retailer trading partners include consumer as well as the supply-chain providers, which will cause some costs when transaction is done. Meanwhile, retailers will generate some costs during daily management activities.

2.2.1 Transaction costs caused by drug providers

Costs of transaction with drug dealers includes: contacting providers and drugs price, negotiation cost, contract cost and execution cost. Compared to traditional model, E-Commerce will help online drug store select the drug producers. So, information technology could help save the cost of contacting providers and contract closing.

2.2.2 Transaction cost caused by consumers

Compared with traditional model, the largest part of expense that online drug store has to pay is delivery and return costs. As mentioned before, drug has high requirements for delivery. Due to competitive situation in drug retail industry and low prof i t in drug selling, the online drug store could not be profitable if the delivery cost is high. On the other hand, once buyers believe that drug is not good, or package is damaged during shipping, then seller may face the risk of return. So, the reverse logistic caused by return will be a heavy burden for online drug stores.

2.2.3 Costs of daily managements

Under the traditional model, drug stores have to rent and employ staffs and pharmacists etc., the costs will be pretty high. Under the model of e-commerce, drug retailers only need to rent a certain place for warehouse and it could lower the cost for cheaper expense. However, online drug store needs the multi-functional talents and their salaries are high. In addition, pre-phase setting of information system will need a huge input. So, medical e-commerce will not cost less in terms of management and maintainments.

In conclusion, the transaction of medical e-commerce B to C model is not obviously lower than traditional retail model. Transaction costs always occur and the difference is just the amount. Big retail drug store is the place where people who want to buy the cheapest drugs can go. With the development of e-commerce, it will offer people one more choice. Whether people will accept the medical E-Commerce depend on the low cost of the new model.

Through the comparison between traditional drug deal and e-commerce B to C model, it is clear that it has no obvious advantage over previous one. People are more willing to choose the traditional transaction model rather than e-commerce for it cannot save a lot.

3 Suggestions for developing medical e-commerce B to C model

To conclude, under the premise of drug quality, the factor to determine the development of medical e-commerce B to C model’s is whether it could lower the transaction cost or not. However, now B to C model has no obvious advantage over traditional one which doesn’t mean this model cannot win in the future. If we can f i nd the way to lower the transaction cost, then B to C model could enjoy a sound development.

3.1 Improving the basic e-commerce environment

First of all, we should build a trust system in society and reduce the uncertainties for both parties in e-commerce through corporates and individual trust center. Then, we have to strengthen the safety of payment. Through these basic improvements of business environment, we could effectively prevent the opportunists’ behavior and lower the cost greatly in e-commerce.

3.2 Accelerating e-commerce legislation and strengthening government supervision

First, we should improve the legal environment for e-commerce and the government should speed up e-commerce legislation to protect both parties’ interests. Second, government should make have a stronger supervision over individual selling drug behavior online, which could be done through regularly exposure of the false drug sales and knock-off drugs websites, releasing the official safe online drug store to reduce the risks for consumers.

3.3 Innovating the drug delivery model

Logistics costs are usually the biggest part of transaction costs which could result in return and exchange when there is the reverse delivery. So, B to C relies on the development of logistics. Government should positively make and implement the policies especially for the third party’s logistics. At the same time, logistics company should also input more capital to upgrade logistics skills and equipment and intergrades the logistics platform to provide better service for e-commerce companies. E-commerce companies should take advantage of the third party and try to lower the delivery cost.

3.4 Fostering drug e-commerce groups

E-commerce model doesn’t fit for all consumers, but drugs are daily necessities, which provide space for the development of e-commerce B to C model. For the retail companies with medical, B to C model, it is of great importance to f i nd out the target market and prepare for the marketing job. The advantage of drug e-commerce is not the price, but convenience and services. So, this f i ts for those with less time but higher salary and they are not sensitive to price, such as the white-collars in downtown. Medical e-commerce companies should take high salary groups as the main marketing targets and gradually draw other consumers to accept this new model.

3.5 Educating consumer to have online purchasing safety awareness

The development of e-commerce needs the active participation of consumers. Government and companies should intensify the publicity of consumer’s online purchasing drugs and raise their awareness and ability to tell the false website and its products. Consumers should be reminded of the seller’s certif i cate when purchasing online and fostering the good habit of buying drugs from the legitimate websites.

3.6 Focusing on customer experience and strengthening brand building

How to better serve the consumers, to attract them and retain them in online pharmacies, we need to constantly improve consumer experience, which could be ref l ected in the processes of online purchasing. It includes searching, recommending, reminding, consulting, delivery and after sales service. So, we need to invest more about brand building, which requires chain store should input lots of resources online and promote its brands in multi-channels to build good brand awareness in consumers heart and form the core competitiveness.

4 Conclusions

Drugs as a standard commodity could be sold online and with the development of e-commerce, we should seize the opportunity and develop the medical e-commerce model in a innovative way. The author tried to study the medical B to C model in transaction cost’s point of view and found that the current situation of e-commerce could not bring down the cost than traditional chain store and that’s why it develops slowly. Therefore, the author put forward some suggestions to lower the transaction costs and it can provide a reference for medical and pharmaceutical chain stores that aim to develop e-commerce in its industry.

[1] China Electronic Commerce Research Center. “2011 China B2C E-commerce Market Research Report” [EB/OL]. http: //b2b. toocle. com/detail--6040170.html

[2] Chinese Online Pharmacies Council [EB/OL]. http://business.sohu. com/20121130/n359142078.shtml

[3] Baidu Encyclopedia [EB/OL]. http://baike.baidu.com/view/45349. htm?fromId=261636

[4] JIANG Ping. Costs of E-commerce Analysis [J]. Modern Corporate Culture, 2008 (5):16-17.

[5]LIU Dan-lei, QIU Jia-xue. Discussion on the Development of Online Pharmacies Problems and Ideas [J]. Shanghai Pharmaceutical, 2012 (6): 44-48.

Author’s information: XING Hua, Associate professor. Major research area: Pharmacy policy and management. Tel: 13504908295, E-mail: gsglxyxh@126.com


登录APP查看全文